Literature DB >> 6779412

Immunological analysis of plasminogen activators from cultured human cancer cells.

S Naito, K Sueishi, F Hattori, K Tanaka.   

Abstract

Immunological similarities or differences between urokinase and plasminogen activators from 9 lines of cultured human cancer cells with varying degrees of fibrinolytic activity were examined with antibodies against human urokinase. The antibodies completely inhibited the fibrinolytic activity of 4 lines of gastric cancer, 2 lines of lung cancer, 1 line of urinary bladder cancer and 1 line of renal cancer, indicating that the plasminogen activators from these cell lines were immunologically identical to urokinase. In 5 out of these cell lines, immunological identity was also confirmed by double diffusion analysis. The plasminogen activator from 1 line of lung cancer was found to be immunologically dissimilar to urokinase by a neutralization experiment and double diffusion analysis. These findings indicate that there are at least two immunologically distinguishable forms of plasminogen activators from human cancer cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779412     DOI: 10.1007/bf00454828

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  20 in total

1.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

Authors:  U R Nilsson; R H Tomar; F B Taylor
Journal:  Immunochemistry       Date:  1972-07

2.  Fibrinolysis in human malignant tumours.

Authors:  H I Peterson; I Kjartansson; K Korsan-Bengtsen; C M Rudenstam; L Zettergren
Journal:  Acta Chir Scand       Date:  1973

3.  No crossreaction between circulating plasminogen activator and urokinase.

Authors:  B Astedt
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

4.  Relationship between fibrinolysis of cultured cells and malignancy.

Authors:  W E Laug; P A Jones; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

5.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

6.  In vitro plasminogen activator activity in human brain tumors.

Authors:  W S Tucker; W M Kirsch; A Martinez-Hernandez; L M Fink
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

7.  Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307

8.  Immunological analysis of plasminogen activators from normal and transformed hamster cells. Evidence that the plasminogen activators produced by SV40 virus-transformed hamster embryo cells and normal hamster lung cells are antigenically identical.

Authors:  J K Christman; S C Silverstein; G Acs
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

9.  Properties of plasminogen activators formed by neoplastic human cell cultures.

Authors:  D B Rifkin; J N Loeb; G Moore; E Reich
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.

Authors:  M Kinjo; K Oka; S Naito; S Kohga; K Tanaka; S Oboshi; Y Hayata; K Yasumoto
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

View more
  6 in total

1.  Establishment of a human renal pelvic cancer cell line producing tissue thromboplastin and plasminogen activator.

Authors:  S Naito; K Tanaka; T Kanamori; S Hisano; S Momose
Journal:  Urol Res       Date:  1982-02

2.  Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1.

Authors:  H Sakuda; Y Nakashima; S Kuriyama; K Sueishi
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

3.  Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gel.

Authors:  A Takei; Y Tashiro; Y Nakashima; K Sueishi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

4.  Conditioned media of carcinoma cells cultured in hypoxic microenvironment stimulate angiogenesis in vitro; relationship to basic fibroblast growth factor.

Authors:  H Ishibashi; K Nakagawa; Y Nakashima; K Sueishi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.

Authors:  A Larsson; B Astedt
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

6.  Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model.

Authors:  Katharina König; Lydia Meder; Cornelia Kröger; Linda Diehl; Alexandra Florin; Ursula Rommerscheidt-Fuss; Philip Kahl; Eva Wardelmann; Thomas M Magin; Reinhard Buettner; Lukas C Heukamp
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.